A device smaller than a quarter is giving heart patients a new lease on life. The Watchman device is implanted in the heart to prevent blood clots from forming without the need of blood thinners.

Washington Regional’s Walker Heart Institute now offers the Watchman FLX Pro Left Atrial Appendage Closure (LAAC) Device. The new device features visualization markers for more precise placement, a ...

Boston Scientific Corporation (NYSE:BSX), a leading player in the medical technology sector, has been making waves in the industry with its innovative product pipeline and strong market performance.

Independence Health System’s Westmoreland Hospital announced that its Heart Lung and Vascular Institute specialists successfully implanted their 500th patient with the WATCHMAN™ left atrial appendage ...

Boston Sci (BSX) presented the data at the American Heart Association’s Scientific ... The company’s latest-generation Watchman FLAX Pro LAAC Device was approved in 2023.

SGMC Health is raising the bar in cardiac care with the introduction of a cutting-edge Cardiac Electrophysiology (EP) Lab at ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.